Referencing Approved Drug Products in ANDA Submissions Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 27, 2020
October 27, 2020
a3f26b8f-0c5a-443b-b665-6fef99ae7de4
Related Documents
Benefit-Risk Assessment for New Drug and Biological Products
Guidance DocumentOctober 17, 2023Center for Drug Evaluation and Research
Elemental Impurities in Drug Products Guidance for Industry
Guidance DocumentAugust 8, 2018Center for Drug Evaluation and Research
Labeling for Biosimilar Products Guidance for Industry
Guidance DocumentJuly 18, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.